Back
Enfusion 10K Form
Buy
56
ENFN
Enfusion
Last Price:
9.70
Seasonality Move:
-16.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ENFN News And Ratings
See the #1 stock for the next 7 days that we like better than ENFN
ENFN Financial Statistics
Sales & Book Value
Annual Sales: | $174.54M |
---|---|
Cash Flow: | $13.39M |
Price / Cash Flow: | 53.53 |
Annual Sales: | $0.75 |
Price / Book: | 12.82 |
Profitability
EPS (TTM): | 0.04000 |
---|---|
Net Income (TTM): | $3.33M |
Gross Margin: | $116.89M |
Return on Equity: | 3.97% |
Return on Assets: | 2.88% |
Enfusion Earnings Forecast
Key Enfusion Financial Ratios
- The Gross Profit Margin over the past 5 years for ENFN is 66.97%.
- The Selling, General & Administrative Expenses for ENFN have been equal to 48.73% of Gross Profit Margin.
- The Research & Development expenses have been 11.40% of Revenue.
- The Interest Expense is -2.90% of Operating Income.
- The Net Earning history of ENFN is 3.45% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Enfusion Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | ENFN |
Website: | enfusion.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.62 |
Quick Ratio: | 3.41 |
Price-to-Earnings
Trailing P/E Ratio: | 135.71 |
---|---|
Forward P/E Ratio: | 32.79 |